Rarity Bioscience
PrivateLast Round
VC Round
Jun 18, 2024
Total Funding Raised
$3.22M
Company Overview
Rarity Bioscience is a biotechnology company that provides ultra-sensitive multiplex assays for mutation detection in liquid biopsies for research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rarity Bioscience Comparables
Compare Rarity Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pillar Biosciences | 77% | |
| AccuraGen | 76% | |
| Sysmex Corporation | 76% | |
Rarity Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 18, 2024 | ||||
| Seed | Feb 6, 2023 | ||||
| Angel | Jul 12, 2021 |
Key People
Founding team and executive leadership
Rarity Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Navigare Ventures | Seed, VC Round |
| Uppsala University Invest | Angel, VC Round, Seed |
| Novalis Biotech | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2025
Presented at the ADLM 2025 event, featuring CEO Linus Bosaeus.
- Sep 9, 2025
SuperRCA assay named fan favorite at ADLM 2025 competition.
Rarity Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rarity Bioscience's valuation, stock price, and market status.